Free Trial
→ Watch This Robotics Demo Before March 17th (From Brownstone Research) (Ad) Free ZVSA Stock Alerts

ZyVersa Therapeutics (ZVSA) SEC Filings & 10K Form

ZyVersa Therapeutics logo
$1.22 0.00 (0.00%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$1.20 -0.02 (-1.64%)
As of 02/21/2025 05:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent ZyVersa Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
12/30/2024
7:30 AM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 424B3
12/26/2024
11:15 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form EFFECT
12/20/2024
4:04 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/20/2024
3:15 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form PRE 14A
11/14/2024
5:01 PM		Anson Funds Management LP (Filed by)
ZyVersa Therapeutics, Inc. (Subject)
ZyVersa Therapeutics, Inc. (Subject)
ZyVersa Therapeutics, Inc. (Subject)
ZyVersa Therapeutics (Subject)
ZyVersa Therapeutics, Inc. (Subject)
Form SC 13G/A
11/14/2024
7:30 AM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:00 AM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:00 AM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:30 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
4:29 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
4:30 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 424B5
09/10/2024
6:25 AM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 424B3
09/10/2024
6:22 AM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 424B3
09/09/2024
11:15 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form EFFECT
09/09/2024
11:15 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form EFFECT
09/09/2024
3:30 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form DEF 14A
09/09/2024
3:32 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form DEFA14A
09/09/2024
3:35 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form ARS
09/03/2024
4:28 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/03/2024
4:29 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/30/2024
4:10 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form PRE 14A
08/09/2024
3:30 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
7:00 AM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
8:35 PM		Finizio Robert G (Reporting)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
8:35 PM		SAPIRSTEIN JAMES (Reporting)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
8:35 PM		Freitag Gregory Gene (Reporting)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
8:35 PM		Park Min-Chul (Reporting)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
8:35 PM		Glover Stephen C. (Reporting)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
8:35 PM		Wolfe Peter (Reporting)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
8:35 PM		Cashmere Karen A. (Reporting)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
11:15 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form EFFECT
07/11/2024
7:44 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form POS AM
05/15/2024
7:25 AM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 10-K/A
05/15/2024
7:30 AM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
3:30 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
3:30 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
7:00 AM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2024
4:25 PM		ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ZVSA) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored
How to trade Executive Order 14154
Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...
Porter & Company | Sponsored
Major AI announcement for 2025
BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI Stocks
Brownstone Research | Sponsored